Tech Center 1600 • Art Units: 1646 1674
This examiner grants 57% of resolved cases
Xiaozhen Xie is an examiner in Art Unit 1646 of Tech Center 1600. He has 696 resolved cases and an allowance rate of 56.6%. The median days to allowance is 1311, which reflects a lengthy and detailed examination process. These metrics suggest a balanced environment where success requires persistence and clear technical differentiation. Practitioners should plan for a timeline that exceeds three and a half years on average.
The interview lift is 65.8%. This is one of the highest lift figures, suggesting that interviews are the single most important factor in securing an allowance with this examiner. Practitioners should prioritize interviews early in the prosecution process to overcome the 56.6% baseline allowance rate. The 696 resolved cases provide a strong statistical foundation for these observations. Given the 1311-day median to allowance, utilizing the 65.8% lift is a critical tactical choice. Overall, the data points to a process where direct communication is highly rewarded and can significantly improve the probability of a grant.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17615959 | ANTI-TNF ANTIBODIES, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF ACTIVE ANKYLOSING SPONDYLITIS | Non-Final OA | Janssen Biotech, Inc. |
| 17470455 | BIOMARKERS AND METHODS FOR ASSESSING PSORIATIC ARTHRITIS DISEASE ACTIVITY | Non-Final OA | The Regents of the University of California |
| 17432177 | LIF THERAPY FOR INDUCING INTESTINAL EPITHELIAL CELL REGENERATION | Final Rejection | Rutgers, the State University of New Jersey |
| 18248280 | TREATMENT OF FLARES IN LUPUS | Final Rejection | ASTRAZENECA AB |
| 17419932 | TEST METHOD FOR ULCERATIVE COLITIS AND PRIMARY SCLEROSING CHOLANGITIS | Non-Final OA | KYOTO UNIVERSITY |
| 18577206 | SYSTEMS AND METHODS FOR DELIVERY BASED ON SUPRAMOLECULAR NANOSTRUCTURES | Non-Final OA | Children's Medical Center Corporation |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy